Found: 7
Select item for more details and to access through your institution.
Systemic increase in IL-26 is associated with severe COVID19 and comorbid obstructive lung disease.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1434186
- By:
- Publication type:
- Article
Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1016991
- By:
- Publication type:
- Article
Elastase- and LPS-Exposed Cpa3<sup>Cre/+</sup> and ST2<sup>-/-</sup> Mice Develop Unimpaired Obstructive Pulmonary Disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.830859
- By:
- Publication type:
- Article
Delayed neutrophil shedding of CD62L in patients with chronic rhinosinusitis with nasal polyps and asthma: Implications for Staphylococcus aureus colonization and corticosteroid treatment.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 3, p. 1, doi. 10.1002/clt2.12347
- By:
- Publication type:
- Article
TLR4-mediated release of heparin-binding protein in human airways: a co-stimulatory role for IL-26.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1178135
- By:
- Publication type:
- Article
Depletion of Mcpt8‐expressing cells reduces lung mast cells in mice with experimental asthma.
- Published in:
- Allergy, 2023, v. 78, n. 5, p. 1363, doi. 10.1111/all.15596
- By:
- Publication type:
- Article
Systemic increase in IL-26 is associated with severe COVID-19 and comorbid obstructive lung disease.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1434186
- By:
- Publication type:
- Article